Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Appointed director

Urovant Sciences Ltd. (UROV) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/31/2021 4 Robinson James A. Jr. (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 8,385 shares @ $0
Disposed/sold 50,000 options to buy @ $12.41, valued at $620.5k
Disposed/sold 25,000 options to buy @ $8.78, valued at $219.5k
Disposed/sold 845,732 rights @ $9.16, valued at $7.7M
03/31/2021 4 Haag-Molkenteller Cornelia (CMO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 11,603 shares @ $0
Disposed/sold 129,745 shares @ $0
Disposed/sold 146,850 options to buy @ $7.53, valued at $1.1M
Disposed/sold 1,000 options to buy @ $13.65, valued at $13.7k
Disposed/sold 100,000 options to buy @ $6.88, valued at $688k
03/31/2021 4 Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 12,480 shares @ $0
Disposed/sold 9,000 shares @ $0
Disposed/sold 13,350 options to buy @ $7.53, valued at $100.5k
Disposed/sold 36,650 options to buy @ $8.01, valued at $293.6k
Disposed/sold 25,000 options to buy @ $8.78, valued at $219.5k
Disposed/sold 15,000 options to buy @ $9.38, valued at $140.7k
03/31/2021 4 BANSAL AJAY (See Remarks) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 24,876 shares @ $0
Disposed/sold 115,222 shares @ $0
Disposed/sold 140,000 options to buy @ $9.66, valued at $1.4M
03/31/2021 4 Hindman James M. (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 9,000 shares @ $0
Disposed/sold 61,000 options to buy @ $10.53, valued at $642.3k
Disposed/sold 15,000 options to buy @ $9.38, valued at $140.7k
03/31/2021 4 Kurstjens Sef (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 12,480 shares @ $0
Disposed/sold 9,000 shares @ $0
Disposed/sold 13,350 options to buy @ $7.53, valued at $100.5k
Disposed/sold 36,650 options to buy @ $8.01, valued at $293.6k
Disposed/sold 25,000 options to buy @ $8.78, valued at $219.5k
Disposed/sold 15,000 options to buy @ $9.38, valued at $140.7k
03/31/2021 4 Johnston Walt (See Remarks) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 492 shares @ $0
Disposed/sold 108,647 shares @ $0
Disposed/sold 69,197 options to buy @ $10.64, valued at $736.3k
03/31/2021 4 Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 9,341 shares @ $0
Disposed/sold 115,106 shares @ $0
Disposed/sold 93,450 options to buy @ $7.53, valued at $703.7k
Disposed/sold 3,500 options to buy @ $13.65, valued at $47.8k
Disposed/sold 20,000 options to buy @ $6.88, valued at $137.6k
03/31/2021 4 OCAMPO CHRISTINE (PAO; CAO/Urovant Sciences,Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 9,810 shares @ $0
Disposed/sold 68,971 shares @ $0
Disposed/sold 133,500 options to buy @ $3.64, valued at $485.9k
Disposed/sold 3,750 options to buy @ $13.65, valued at $51.2k
Disposed/sold 70,000 options to buy @ $6.88, valued at $481.6k
03/31/2021 4 POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Disposed/sold 12,480 shares @ $0
Disposed/sold 9,000 shares @ $0
Disposed/sold 50,000 options to buy @ $8.01, valued at $400.5k
Disposed/sold 25,000 options to buy @ $8.78, valued at $219.5k
Disposed/sold 15,000 options to buy @ $9.38, valued at $140.7k
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2021 4 Haag-Molkenteller Cornelia (CMO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Paid exercise price by delivering 5,810 shares @ $16.09, valued at $93.5k
01/08/2021 4 Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Paid exercise price by delivering 4,761 shares @ $16.09, valued at $76.6k
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2020 4 Johnston Walt (SVP, Commercial, USI) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 108,647 shares @ $0
Granted 69,197 options to buy @ $10.64, valued at $736.3k
06/03/2020 3 Johnston Walt (SVP, Commercial, USI) has filed a Form 3 on Urovant Sciences Ltd.
06/01/2020 4 Hindman James M. (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 61,000 options to buy @ $10.53, valued at $642.3k
06/01/2020 3 Hindman James M. (Director) has filed a Form 3 on Urovant Sciences Ltd.
05/04/2020 4 Haag-Molkenteller Cornelia (CMO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 83,149 shares @ $0
05/04/2020 4 Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 77,606 shares @ $0
05/04/2020 4 OCAMPO CHRISTINE (PAO;CAO/Urovant Sciences, Inc) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 44,346 shares @ $0
05/04/2020 4 BANSAL AJAY (PFO;CFO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 63,659 shares @ $0
03/25/2020 4 Robinson James A. Jr. (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 845,732 rights @ $9.16, valued at $7.7M
02/21/2020 4 Katkin Keith (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Paid exercise price by delivering 104,788 shares @ $13.08, valued at $1.4M
Disposed of 75,212 shares @ $13.08, valued at $983.8k
Exercised 180,000 options to buy @ $3.86, valued at $694.8k
02/21/2020 4 Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Paid exercise price by delivering 34,835 shares @ $13.08, valued at $455.6k
Disposed of 15,165 shares @ $13.08, valued at $198.4k
Exercised 50,000 options to buy @ $6.88, valued at $344k
02/21/2020 4 Sumitomo Chemical Co., Ltd. (See Footnote (1)) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Bought 12,873 shares @ $13.08, valued at $168.4k
Bought 15,165 shares @ $13.08, valued at $198.4k
Bought 75,212 shares @ $13.08, valued at $983.8k
01/14/2020 4 Robinson James A. Jr. (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 12,480 shares @ $0
01/14/2020 4 POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 12,480 shares @ $0
01/14/2020 4 Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 12,480 shares @ $0
01/14/2020 4 Kurstjens Sef (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 12,480 shares @ $0
01/09/2020 4 Katkin Keith (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 199,680 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy